Flu Vaccine Responses in the Setting of Melanoma Treatment
Flu Vaccine Responses in the Setting of Melanoma Treatment
Influenza vaccination is indicated for all adults, but the immunogenicity of vaccination has
 not been assessed in all situations. We are conducting a prospective unblinded study of
 influenza vaccine recipients.
Influenza vaccination is indicated for all adults, but the immunogenicity of vaccination has
 not been assessed in all situations. In particular, immune responses following influenza
 vaccination have not been studied in the setting of advanced melanoma and in the context of
 various anti-tumor treatments. In this study, we will look at the immune response of subjects
 receiving vaccination.
Inclusion Criteria:

 -  adults capable of providing consent

 -  have a diagnosis of locally advanced or metastatic melanoma

 Exclusion Criteria:

 -  are allergic to influenza vaccination

 -  have received influenza vaccination within the past 6 months

 -  require prednisone, methotrexate, or other immunosuppressing medications

 -  have HIV infection

 -  have a history of solid organ or bone marrow transplant

 -  require combination immunotherapy

 -  are on other studies requiring blood draws that might exceed 450 mL total during the
 period of the influenza vaccine study